Skip to content
  • Tuesday, 16 June 2026
  • 2:57 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • AvenCell Therapeutics Unveils Promising Early Data for Switchable Allogeneic CAR-T Therapy in Relapsed/Refractory AML at EHA 2026
Pharmaceutical R&D

AvenCell Therapeutics Unveils Promising Early Data for Switchable Allogeneic CAR-T Therapy in Relapsed/Refractory AML at EHA 2026

Teuku Ryan Jun 16, 2026 0

AvenCell Therapeutics presented updated results for its CAR-T cell blood cancer therapy at EHA 2026. The European Hematology Association (EHA)…

Read More
Enhancing Cancer Genomics: How Droplet Digital PCR Overcomes Next-Generation Sequencing Bottlenecks for Precision OncologyProtecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma InnovationFrom funky smells to crafty colors, orchids have some weird ways of attracting pollinatorsEvidence for the Formation of Eta-Prime Mesic Nuclei and Its Implications for the Origin of Mass in the Universe
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Professor Peter Tessier Pioneers AI-Driven Solutions for Antibody Deliverability ChallengesSalesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharmaEngineered Metamaterials Breakthrough Unlocks Precision Control of Heat Transfer at the NanoscaleAvenCell Therapeutics Unveils Promising Early Data for Switchable Allogeneic CAR-T Therapy in Relapsed/Refractory AML at EHA 2026
YOU MAY HAVE MISSED
Biotech & Genetic Research
Professor Peter Tessier Pioneers AI-Driven Solutions for Antibody Deliverability Challenges
Jia Lissa Jun 16, 2026
Laboratory Automation & Robotics
Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma
Lana Keisha Jun 16, 2026
Advanced Materials Science
Engineered Metamaterials Breakthrough Unlocks Precision Control of Heat Transfer at the Nanoscale
Nila Kartika Wati Jun 16, 2026
Pharmaceutical R&D
AvenCell Therapeutics Unveils Promising Early Data for Switchable Allogeneic CAR-T Therapy in Relapsed/Refractory AML at EHA 2026
Teuku Ryan Jun 16, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ